tradingkey.logo

Novo's Wegovy pill tracks 18,410 prescriptions for first full week since launch

ReutersJan 23, 2026 12:28 PM

- Novo Nordisk's NOVOb.CO Wegovy pill tracked 18,410 U.S. prescriptions in the first full week after its launch, IQVIA data shared by an analyst on Friday showed.

Investors are closely watching prescriptions data to see if the Danish drugmaker can press its first-mover advantage against rival Eli Lilly LLY.N in a competitive weight-loss market.

The pill hit 3,071 U.S. prescriptions in the first four days after its launch.

"We note this is tracking ahead of other GLP-1 launches," Guggenheim analysts said in a note.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI